Business
Scientific advisors & partners update
IXICO plc has expanded its Scientific Advisory Board with the addition of leading experts in Alzheimer's and Parkinson's disease, Professor Jeffrey Cummings, Professor Charles DeCarli, and Professor Stéphane Lehéricy, to enhance its neuroscience imaging and biomarker analytics capabilities. The company has also initiated two new scientific R&D initiatives in Parkinson's disease, including a research collaboration with the Paris Brain Institute to evaluate novel neuromelanin-sensitive MRI approaches and participation in The Michael J. Fox Foundation's MRI Advisory Committee to advance quantitative MRI biomarkers for Parkinson's research. These developments aim to strengthen IXICO's position in the central nervous system drug development sector. Disclaimer*
About this update from Ixico Plc
IXICO plc ("IXICO", the "Company" or the "Group") IXICO EXPANDS RESEARCH COLLABORATIONS IN ALZHEIMER'S AND PARKINSON'S DISEASE Professor Jeffrey Cummings and Professor Charles DeCarli in the field of Alzheimer's Disease, and Professor Stéphane Lehéricy in the field of Parkinson's Disease join the IXICO Scientific Advisory Board Parkinson's disease research activities include collaboration with the Paris Brain Institute and advisory role with The Michael J. Fox Foundation for Parkinson's Research 08 June 2026, IXICO plc (AIM: IXI) - London, UK. IXICO, a global leader in neuroscience imaging and biomarker analytics, using its AI-driven platform to help advance drug development in neurological disorders, today announced it has added three further global experts with Professor Cummings and Professor DeCarli, leading KOLs in Alzheimer's Disease (AD) and, Professor Lehéricy a leading KOL in Parkinson's Disease (PD), to its Scientific Advisory Board. IXICO also announced today that it has entered into two scientific R&D initiatives in the field of PD. Scientific Advisory Board Additions Professor Jeffrey Cummings, MD, ScD, University of Nevada Las Vegas Jeff is the Joy Chambers-Grundy Professor of Brain Science, Director of the Chambers-Gundy Center for Transformative Neuroscience, Co-Director of the Pam Quirk Brain Health and Biomarker Laboratory, Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas (UNLV). A full biography is available in the notes at the bottom of this announcement. Professor Charles DeCarli, MD, University of California Charles is Distinguished Professor of Neurology at the University of California in Davis, California and recipient of the Victor and Genevieve Orsi Chair in Alzheimer's Research. He is Co-Director of the UC Davis Alzheimer's Disease Research Center (UCD ADRC), and Chief of the Imaging of Dementia and Aging (IDeA) laboratory. A full biography is available in the notes at the bottom of this announcement. Professor Stéphane Lehéricy, MD, Paris Brain Institute Stéphane Lehéricy is Professor of Neuroradiology and head of the neuroradiology department at the Pitié-Salpêtrière Hospital (Paris) and Director of CENIR (Centre de neuro-imagerie de recherche) at the Paris Brain Institute. His...